लोड हो रहा है...
The pleiotropic cardiovascular effects of dipeptidyl peptidase‐4 inhibitors
Patients with Type 2 diabetes have an excess risk for cardiovascular disease. One of the several approaches, included in the guidelines for the management of Type 2 diabetes, is based on dipeptidyl peptidase 4 (DPP‐4; also termed CD26) inhibitors, also called gliptins. Gliptins inhibit the degradati...
में बचाया:
| में प्रकाशित: | Br J Clin Pharmacol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley and Sons Inc.
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6046494/ https://ncbi.nlm.nih.gov/pubmed/29667232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13611 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|